1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)- | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]-
USP

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

Contact Supplier

Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.

Contact Supplier

With Virupaksha, you get a quality product with on-time delivery.

Contact Supplier

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]-

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 9 USDMF, 2 EU WC, 8 NDC API, 9 Listed Suppliers, $ API Reference Price

17 API Suppliers
9 USDMF
2 EU WC
8 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 26 FDA Orange Book, 15 Europe, 5 Canada

46 FDF Dossiers
26 FDA Orange Book
15 Europe
5 Canada

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 200MG, TABLET;ORAL - 400MG

SUSPENSION;ORAL - 40MG/ML
TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 200MG
TABLET;ORAL - 400MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 7 SPI Pharma, 11 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 29 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

55 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 30 Thickeners and Stabilizers, 25 Controlled & Modified Release, 20 Direct Compression, 18 Film Formers & Plasticizers, 16 Granulation, 15 Topical, 14 Lubricants & Glidants, 13 Taste Masking, 12 Rheology Modifiers, 11 Solubilizers, 10 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

55 Fillers, Diluents & Binders
49 Coating Systems & Additives
30 Thickeners and Stabilizers
25 Controlled & Modified Release
20 Direct Compression
18 Film Formers & Plasticizers
16 Granulation
15 Topical
14 Lubricants & Glidants
13 Taste Masking
12 Rheology Modifiers
11 Solubilizers
10 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 Parenteral
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

21 News #PharmaBuzz

21 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 13 Annual Reports

2 US Medicaid Prescriptions
15 Regulatory FDF Prices
13 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

3 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,718 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11606401

02 11606412

03 11606423

filter Description Reset all filters

3 All

01 1Rufinamide (200 mg)

02 1Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide)

03 1Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate)

filter CAS Number Reset all filters

3 All

01 1106308-41-2

02 1106308-44-5

03 1217448-86-7

Product Main Page

US Pharmacopeia

AAN

Not Confirmed

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Rufinamide (200 mg)

CAS Number : 106308-44-5

Quantity Per Vial :

Price ($) : 675

Catalog Number : 1606401

Current Lot : F0K298

Previous Lot :

NDC Code :

Product Web Link

Digital Content

US Pharmacopeia

AAN

Not Confirmed

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Rufinamide Related Compound A (25 mg) (1-(2-F...

CAS Number : 106308-41-2

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1606412

Current Lot : F0K299

Previous Lot :

NDC Code :

Product Web Link

Digital Content

US Pharmacopeia

AAN

Not Confirmed

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Rufinamide Related Compound B (25 mg) (Methyl...

CAS Number : 217448-86-7

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1606423

Current Lot : F0K300

Previous Lot :

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!